Cambridge, USA-based Vesalius Therapeutics has entered into a multi-target strategic alliance with the UK’s GSK to discover ...

DelveInsight's Dermatological Drugs Market Insights report provides the current and forecast market analysis, individual ...

The number of ISA millionaires is growing all the time and guess what? They're really into blue-chip dividend shares listed ...

After years of limited advancements in chronic obstructive pulmonary disease (COPD) treatment, patients now have new options.

Consider taking independent financial advice. Mark Hartley has positions in AstraZeneca Plc and GSK. The Motley Fool UK has recommended AstraZeneca Plc, GSK, Rolls-Royce Plc, Tesla, and Workday. Views ...

Multiple sclerosis (MS) is a chronic neurological disorder affecting the central nervous system (CNS), particularly the brain, spinal cord, and optic nerves. Continuous research has led to new drug ...

Multiple sclerosis (MS) is a chronic neurological disorder affecting the central nervous system (CNS), particularly the brain ...

Following the recent U.S. elections, domestic equity ETFs experienced a surge in inflows, largely directed at large-cap core ...

Analysts at Williams Trading and BTIG have upgraded their ratings for On Holding AG (ONON) to Buy from Hold/Neutral, ...

Derya Matras will be the new Vice President for Meta in Europe, Middle East and Africa, taking over from Angie Gifford, who announced that she will be leaving her role as VP of EMEA at the end of this ...

It’s sad to see how other leagues are overtaking us at an incredible speed when we have the potential to be a top league — ...

As I say, its share price slumped from late March after the company went ex-dividend. And it’s continued to struggle since ...